Ross Bundy is a visionary leader specializing in commercializing complex technologies across deep tech and life sciences. With over 11 years of entrepreneurial experience, he has successfully founded companies, raised capital, commercialized pioneering technologies, built high-performing teams, and executed strategic exits. Currently serving as CEO of CRISPR QC, Bundy is advancing biosensor technology to optimize precision and efficiency in genome editing, fueling innovation in diagnostics, therapeutics, and bioinformatics.
As the founding CEO of Cardea Bio (originally Nanomedical Diagnostics), Bundy spearheaded the commercialization of the world’s first graphene-based biosensors, effectively launching the “Internet of Biology”—a revolutionary approach to real-time molecular analysis. Under his strategic direction, Cardea Bio achieved significant market traction, leading to its acquisition in April 2023, during which Bundy strategically spun out CRISPR QC to further leverage the underlying technology.
Bundy’s career is marked by a consistent ability to identify commercialization pathways for groundbreaking technologies, extending beyond biosensors to include previous successes in semiconductor markets. Prior to his entrepreneurial ventures, he developed extensive expertise in supply chain management, business development, procurement, and financial planning during his tenure at General Dynamics/NASSCO and Bumble Bee Foods, providing a robust foundation for operational excellence and strategic decision-making.
Bundy holds an MBA in Program Management from San Diego State University and a BA in History from the University of California, San Diego. His areas of expertise include corporate strategy, financial management, federal acquisition regulations, and operational improvement. Passionate about turning cutting-edge science into commercially viable solutions, Bundy is committed to driving innovation and creating sustained value for businesses, partners, and society.
Character
Ross Bundy is a dynamic innovator dedicated to turning scientific breakthroughs into commercial successes. His integrity, adaptability, and entrepreneurial spirit inspire teams to achieve ambitious goals while remaining committed to meaningful innovation.
Knowledge
Bundy possesses deep expertise in commercializing advanced technologies across biosensors, semiconductors, and biotechnology applications. His extensive knowledge in business development, supply chain operations, and financial strategy uniquely positions him to bridge the gap between science and the marketplace.
Strategic
Known for aligning scientific innovation with market demands, Bundy has repeatedly demonstrated success in identifying commercial opportunities, securing strategic partnerships, scaling operations, and successfully navigating company acquisitions and exits.
Communication
An adept communicator, Bundy translates complex technical and business concepts into clear, compelling narratives. His skill in fostering collaborative relationships and articulating strategic visions has consistently advanced organizational objectives and industry-wide innovation.
